Delving into the Latest Updates on Changchun Huapu Biotechnology Co. Ltd. with Synapse

Overview

Tags

Neoplasms

Digestive System Disorders

Skin and Musculoskeletal Diseases

Oligonucleotide

Chemical drugs

Fusion protein

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	5
Infectious Diseases	2

Top 5 Drug Type	Count

Chemical drugs	1
Prophylactic vaccine	1
Fusion protein	1
Oligonucleotide	1
Genetically engineered subunit vaccine	1

Top 5 Target	Count

TLR9(Toll like receptor 9)	3
TGF-β x VEGF	1
IL15 / IL15R(IL15 / IL15 Receptor)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 15 Mar 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

2

1

Preclinical

IND Approval

1

3

Phase 1

Other

2

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

HP007 ( TLR9 )	Advanced Malignant Solid Neoplasm More	Phase 1
Recombinant Zoster Vaccine(CHO Cell)(Huapu)	Herpes Zoster More	Phase 1
FS-8002 ( TGF-β x VEGF )	Advanced Malignant Solid Neoplasm More	Phase 1
Recombinant Hepatitis B Vaccine (Hansenula, CpG and Aluminum Adjuvant)(Huapu Shijiazhuang)	Hepatitis B More	IND Approval
HP-06T07 ( TLR9 )	Colonic Cancer More	Preclinical